XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.250
-0.010 (-0.79%)
Nov 21, 2024, 11:32 AM EST - Market open
XORTX Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 2.27 | 2.28 | 1.93 | 1.22 | 0.51 | 0.4 | |
Research & Development | 0.31 | 2.42 | 6.76 | 0.68 | 0.28 | 0.04 | |
Operating Expenses | 2.84 | 4.96 | 9.24 | 2.31 | 1.1 | 0.49 | |
Operating Income | -2.84 | -4.96 | -9.24 | -2.31 | -1.1 | -0.49 | |
Interest Expense | - | - | - | -0 | -0.01 | -0.04 | |
Interest & Investment Income | 0.15 | 0.25 | 0.1 | - | - | - | |
Currency Exchange Gain (Loss) | -0.02 | -0.01 | -0 | -0.01 | 0 | -0.03 | |
Other Non Operating Income (Expenses) | 1.98 | 2.55 | 1.42 | 0.75 | -0.2 | -0.08 | |
EBT Excluding Unusual Items | -0.74 | -2.16 | -7.72 | -1.58 | -1.31 | -0.63 | |
Asset Writedown | - | - | - | - | -0.06 | - | |
Other Unusual Items | - | - | - | - | 0.09 | - | |
Pretax Income | -0.74 | -2.16 | -7.72 | -1.58 | -1.28 | -0.63 | |
Net Income | -0.74 | -2.16 | -7.72 | -1.58 | -1.28 | -0.63 | |
Net Income to Common | -0.74 | -2.16 | -7.72 | -1.58 | -1.28 | -0.63 | |
Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 1 | |
Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 1 | |
Shares Change (YoY) | 36.19% | 33.91% | 35.25% | 47.77% | 24.34% | 1.79% | |
EPS (Basic) | -0.29 | -1.09 | -5.22 | -1.44 | -1.73 | -1.06 | |
EPS (Diluted) | -0.29 | -1.09 | -5.22 | -1.44 | -1.73 | -1.06 | |
Free Cash Flow | -4.09 | -6.59 | -8.98 | -4.8 | -0.73 | -0.25 | |
Free Cash Flow Per Share | -1.60 | -3.32 | -6.07 | -4.39 | -0.98 | -0.42 | |
EBITDA | -2.77 | -4.88 | -9.22 | -2.3 | -1.08 | -0.47 | |
D&A For EBITDA | 0.07 | 0.07 | 0.02 | 0.01 | 0.02 | 0.02 | |
EBIT | -2.84 | -4.96 | -9.24 | -2.31 | -1.1 | -0.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.